Leishmaniases. Epidemiological Report of the Americas, December 2019
Date
2019-12Metadata
Show full item recordAbstract
[Introduction]. Since 2012, the year of the beginning of the Regional Information System for Leishmaniases in the Americas (SisLeish), countries have been making great effort to include the data within the required time, which is April 30th of the subsequent year. One of the performance indicators of the Plan of Action for Leishmaniases in the Americas 2017-2022 is the number of endemic countries that timely report the cutaneous/mucosal and visceral leishmaniasis data at the second administrative political level in SisLeish. In 2013, from the 17 countries that report data to PAHO/WHO, 29% entered the data until the scheduled date, 18% up to three months later (July 30th) and 53% six months later (October 30th).
Table of contents
Introduction | Epidemiological Status: Cutaneous and mucosal leishmaniasis; Visceral Leishmaniasis | Final considerations | References
Series
Subject
Category of PAHO Strategic Plan 2014-2019
Related items
Showing items related by title, author, creator and subject.
-
Leishmaniases. Epidemiological Report in the Americas, July 2016
Pan American Health Organization (Washington, D.C., PAHO, 2016-07)[Introduction]. The leishmaniases are vector-borne diseases with a zoonotic cycle in the Americas and remain a problem to public health. This disease presents a high burden capable of yielding severe clinical forms that ... -
Leishmaniases. Epidemiological Report in the Americas, February 2018
Pan American Health Organization (Washington, D.C., PAHO, 2018-02)[Introduction]. The leishmaniasis are diseases with elevated incidence rate and wide geographic distribution in the Americas. They remain a challenge for national and regional programs, since they require a technical, ... -
Leishmaniases. Epidemiological Report of the Americas, December 2020
Pan American Health Organization; Communicable Diseases and Environmental Determinants of Health (CDE) (Washington, D.C., PAHO, 2020-12-03)In the Americas, leishmaniasis are a public health problem due to their magnitude and geographic distribution and because they produce clinical forms that can cause death, disability, and mutilation. In recent years, the ...